182 related articles for article (PubMed ID: 34379804)
1. A proposal for risk-based and strategy-adapted de-escalation in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Wotman MT; Miles BA; Bakst RL; Posner MR
Cancer; 2021 Dec; 127(23):4330-4338. PubMed ID: 34379804
[No Abstract] [Full Text] [Related]
2. De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma-Where Are We Now?
Silver JA; Turkdogan S; Roy CF; Subramaniam T; Henry M; Sadeghi N
Curr Oncol; 2022 May; 29(5):3668-3697. PubMed ID: 35621685
[TBL] [Abstract][Full Text] [Related]
3. Updates on Human Papillomavirus-driven oropharyngeal squamous cell carcinomas in a southern European country.
Donà MG; Rollo F; Pichi B; Moretto S; Covello R; Pellini R; Benevolo M
Oral Oncol; 2022 Aug; 131():105947. PubMed ID: 35667293
[No Abstract] [Full Text] [Related]
4. Chemoradiotherapy in Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma. Cetuximab is Inferior to Cisplatin - is the Case now Closed?
Donnelly O; Kelly C; Iqbal MS
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):783-785. PubMed ID: 35945073
[No Abstract] [Full Text] [Related]
5. Human papillomavirus-related oropharyngeal carcinoma.
Saito Y; Homma A; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ota I; Yokota T; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Tanaka K; Onoe T; Okano S; Imamura Y; Ariizumi Y; Hayashi R
Jpn J Clin Oncol; 2022 Jul; 52(7):700-706. PubMed ID: 35383359
[TBL] [Abstract][Full Text] [Related]
6. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
Taku N; Wang L; Garden AS; Rosenthal DI; Gunn GB; Morrison WH; Fuller CD; Phan J; Reddy JP; Moreno AC; Spiotto MT; Chronowski G; Shah SJ; Mayo LL; Gross ND; Ferrarotto R; Zhu XR; Zhang X; Frank SJ
Curr Treat Options Oncol; 2021 Jun; 22(6):54. PubMed ID: 34086150
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
Morand GB; Cardona I; Cruz SBSC; Mlynarek AM; Hier MP; Alaoui-Jamali MA; da Silva SD
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955529
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus and Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region: A Comprehensive Review on Clinical Implications.
Larsen MHH; Channir HI; von Buchwald C
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372502
[TBL] [Abstract][Full Text] [Related]
9. Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.
Rosenberg AJ; Vokes EE
Oncologist; 2021 Jan; 26(1):40-48. PubMed ID: 32864799
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status.
Robinson SD; Towler JD; Kitson R; Saleh D; Younan HC; Mukhopadhyay S; Weir J; Gujral DM
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e614. PubMed ID: 34412969
[No Abstract] [Full Text] [Related]
11. An HPV-Vaccinated Patient With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Garset-Zamani M; von Buchwald C; Karevold G; Agander TK; Mateu-Regué À; Eide HA; Tvedskov JF
JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):92-94. PubMed ID: 36416857
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
Moore EJ; Van Abel KM; Routman DM; Lohse CM; Price KAR; Neben-Wittich M; Chintakuntlawar AV; Price DL; Kasperbauer JL; Garcia JJ; Hinni ML; Patel SH; Janus JR; Foote RL; Ma DJ
Head Neck; 2021 Jan; 43(1):229-237. PubMed ID: 32969095
[TBL] [Abstract][Full Text] [Related]
13. De-Escalation Treatment for Human Papillomavirus-Related Oropharyngeal Cancer: Questions for Practical Consideration.
Chen AM
Oncology (Williston Park); 2023 Jul; 37(7):281-287. PubMed ID: 37499250
[TBL] [Abstract][Full Text] [Related]
14. De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma.
Economopoulou P; Kotsantis I; Psyrri A
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578368
[TBL] [Abstract][Full Text] [Related]
15. Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
Mirza FA; Johnson CZ; Byrd JK; Albergotti WG
Head Neck; 2021 Nov; 43(11):3476-3492. PubMed ID: 34499392
[TBL] [Abstract][Full Text] [Related]
16. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
[TBL] [Abstract][Full Text] [Related]
18. [ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy].
Fabian A; Nicolay NH; Krug D
Strahlenther Onkol; 2022 Nov; 198(11):1045-1048. PubMed ID: 35913504
[No Abstract] [Full Text] [Related]
19. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
[TBL] [Abstract][Full Text] [Related]
20. RNA in situ hybridization for human papillomavirus testing in oropharyngeal squamous cell carcinoma on a routine clinical diagnostic platform.
Henley-Smith R; Santambrogio A; Andoniadou CL; Odell E; Thavaraj S
J Oral Pathol Med; 2021 Jan; 50(1):68-75. PubMed ID: 32840920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
